 Two Sigma Advisers LP raised its position in Ovid Therapeutics Inc NASDAQ:OVID by 21.9 during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission SEC. The firm owned 23,400 shares of the companys stock after buying an additional 4,200 shares during the quarter. Two ... 